More on MNPR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-68.8% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (11/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Monopar Therapeutics (NQ:MNPR)
Delayed: 117.57 +5.64 (5.04%)
Prev. Close $111.93  
Open$110.21 
52 Wk High$ 
52 Wk Low$ 
Day High$118.00 
Day Low$110.21 
P/E N/A  
EPS$ 
Volume95,174 


Aug 28, 2026 08:18 PM Form 4/A Monopar Therapeutics For: Aug 26 Filed by: Tsuchimoto Kim R
Aug 28, 2026 07:41 PM Form 4/A Monopar Therapeutics For: Aug 25 Filed by: Anderson Raymond
Aug 27, 2026 07:29 PM Form 4 Monopar Therapeutics For: Aug 26 Filed by: RIOUX PATRICE
Aug 27, 2026 06:29 PM Form 4 Monopar Therapeutics For: Aug 26 Filed by: Tsuchimoto Kim R
Aug 27, 2026 06:28 PM Form 4 Monopar Therapeutics For: Aug 25 Filed by: Anderson Raymond
Aug 26, 2026 04:20 PM Form 144 Monopar Therapeutics Filed by: RIOUX PATRICE
Aug 26, 2026 04:18 PM Form 144 Monopar Therapeutics Filed by: Tsuchimoto Kim R
Aug 25, 2026 04:45 PM Form 144 Monopar Therapeutics Filed by: Anderson Raymond
Aug 19, 2026 08:00 AM Monopar names medical affairs chief, gets two AASLD presentations
Aug 19, 2026 08:00 AM Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026
View All Articles

Entities mentioned with MNPR

View All Entities